tuneTypical Dose
960 mg daily of aged garlic extract for 12 weeks, with other studies using different standardized preparations
Botanical
Allium sativum
tuneTypical Dose
960 mg daily of aged garlic extract for 12 weeks, with other studies using different standardized preparations
watchEffect Window
Blood-pressure and lipid effects generally take weeks, not days.
check_circleCompliance
WADA NOT PROHIBITED
Overview
Garlic extract can modestly lower blood pressure and improve some lipid markers, especially in higher-risk adults, but it is an adjunctive cardiometabolic supplement rather than a natural statin or antimicrobial cure-all.
Garlic has one of the more real but still modest cardiovascular evidence bases among common botanicals. The strongest human evidence supports small reductions in blood pressure and some lipid improvements, especially in adults with hypertension or worse baseline cardiometabolic risk. The evidence does not support treating garlic as a substitute for antihypertensives, statins, or antibiotics. Formulation matters, with many positive studies using aged garlic extract or other standardized preparations.
Garlic contains sulfur compounds such as allicin derivatives and S-allylcysteine that may affect vascular tone, endothelial function, and lipid metabolism. Those mechanisms are plausible, but the human evidence is still best framed around modest blood-pressure and lipid effects rather than broad antimicrobial or anti-atherosclerotic claims.
Outcomes
Safety
Evidence
Du Y, Zhang Q, Liu S, et al. Effects of Garlic Supplementation on Cardiovascular Risk Factors in Adults. A comprehensive updated systematic review and meta-analysis of randomized controlled trials. Nutrients. 2025;17(12):2051. doi:10.3390/nu17122051. PMID:40580481.
Population: Adults across randomized controlled trials of garlic supplementation for cardiovascular risk factors.
Dose protocol: Various garlic supplement protocols across randomized cardiometabolic trials
Key findings: Modest improvements in blood pressure and lipid markers, strongest in adults with worse baseline risk.
Notes: Best current overview for the supplement’s main use case.
This updated 2025 meta-analysis is the best current high-level source for garlic's cardiometabolic use case. It supports modest improvements in blood pressure and lipids, particularly in adults who start with worse cardiovascular risk profiles. It does not support treating garlic as a substitute for statins, antihypertensives, or antimicrobial therapy.
Wang HP, Yang J, Qin LQ, et al. Garlic for hypertension. A systematic review and meta-analysis of randomized controlled trials. World J Gastroenterol. 2015;21(16):4935-4948. doi:10.3748/wjg.v21.i16.4935. PMID:25837272.
Population: Adults in randomized placebo-controlled trials of garlic for hypertension.
Dose protocol: Garlic-only formulations in hypertensive adults
Key findings: Reduced systolic and diastolic blood pressure versus placebo.
Notes: Main blood-pressure meta-analysis anchor.
This meta-analysis remains a key blood-pressure source because it quantified the modest but real antihypertensive effect of garlic-only formulations. The benefit is clinically relevant enough to justify adjunctive use framing, but still far short of evidence for replacing standard antihypertensive therapy.
Gharagozloo Hesari N, Jahanian Sadatmahalleh S, Mohebbi P, Nasiri M, Khosravi A. Efficacy of garlic (Allium sativum) on metabolic syndrome components in women with polycystic ovary syndrome: randomized controlled trial. J Health Popul Nutr. 2025;44(1). doi:10.1186/s41043-025-01025-8. PMID:40770379.
Population: Women with PCOS and metabolic syndrome.
Dose protocol: 500 mg garlic tablets (2-3 mg allicin) twice daily for 8 weeks
Key findings: Significant improvements in fasting blood sugar (10.5%), triglycerides (17.8%), LDL cholesterol (14.2%), and CRP (24.7%) versus placebo.
Notes: Extends garlic's cardiometabolic evidence to younger women with PCOS and metabolic syndrome.
This RCT tested 500 mg garlic tablets (containing 2-3 mg allicin) twice daily for 8 weeks in 97 women with PCOS and metabolic syndrome. The garlic group showed significant improvements across multiple metabolic markers compared to placebo, including a 10.5% reduction in fasting blood sugar, 17.8% reduction in triglycerides, 14.2% reduction in LDL cholesterol, and 24.7% reduction in C-reactive protein. Blood pressure and BMI also improved. The study extends garlic's cardiometabolic evidence base to a younger female population with hormonal metabolic dysfunction, supporting the broader pattern that garlic supplementation provides the most benefit in people with elevated baseline metabolic risk.
Ried K, Frank OR, Stocks NP, et al. Aged garlic extract lowers blood pressure in patients with treated but uncontrolled hypertension. A randomised controlled trial. Maturitas. 2010;67(2):144-150. doi:10.1016/j.maturitas.2010.05.016. PMID:20594781.
Population: Adults with treated but uncontrolled hypertension.
Dose protocol: 960 mg aged garlic extract daily for 12 weeks
Key findings: Lowered systolic blood pressure in adults with treated but uncontrolled hypertension.
Notes: Practical RCT with a real-world hypertensive population.
This aged-garlic trial is the best practical RCT for blood-pressure framing because it studied a real-world population with treated but uncontrolled hypertension. The systolic reduction was meaningful enough to support adjunctive use, but the sample was still small and the evidence remains formulation specific.